Dermatology OTC medications Market is Slated to Reach US$ 2,316.2 Mn by 2030

Dermatology OTC Medications Market: Introduction

OTC drugs are those that can be purchased without a prescription at all. Analgesics, or painkillers commonly referred to as over-the-counter or non-prescription pharmaceuticals, include aspirin and acetaminophen.

Reports and Insights predicts that the global dermatology OTC medications market is expected to grow at a CAGR of 4.3% during the forecast period from 2022 to 2030. Furthermore, the total value of the global dermatology OTC medications market is slated to reach US$ 2,316.2 Mn by 2030, rising from US$ 1,651.9 Mn in 2022.

Market Report Outlook:

This report on the global dermatology OTC medications market aims to discuss market dynamics, including market drivers, potential threats and challenges to the market, global dermatology OTC medications market opportunities for the major players, global dermatology OTC medications market trends, market segmentation outlook, regional outlook, global dermatology OTC medications market size, market forecast, market share, as well as the major players operating in the global dermatology OTC medications market.

Dermatology OTC Medications Market: Dynamics

The fast development of skin abnormalities and the growing accessibility of over-the-counter (OTC) dermatological treatments are the primary market growth factors. A growing OTC market is also predicted to boost market expansion during the anticipated timeframe. The market is being driven by the rise in middle-class wages and a high incidence of skin conditions.

Download Free Sample Report

Many skin disorders are also associated with aging and are said to affect older persons more frequently. The aging population is also expected to increase the burden of skin problems globally, which will promote the growth of the market for dermatological over-the-counter medications.

Acne is one of the most common skin conditions in the world.  Although acne is most prevalent in teenagers, it affects people of all ages, therefore it is anticipated to hold a sizable piece of the market over the study's predicted period. There are various OTC acne drugs available, including Acnex, Differin, Plixda, and Acne Clear.

OTC drugs are available over the counter and do not need to be taken under a doctor's care, therefore people frequently use them, which can have several harmful effects, such as the development of skin allergies. As a result, the OTC dermatological market might experience a drop.

OTC pharmaceuticals will see an increase in demand as a result of being more widely accessible and less expensive than prescription drugs. For the market players, this will present enormous growth opportunities.

Dermatology OTC Medications Market: Regional Outlook

The worldwide Dermatology OTC medications market consists of Africa, Asia-Pacific, Europe, Latin America, the Middle East, North America, and the rest of the world.

North America is predicted to dominate the market for dermatological OTC drugs during the forecast period. This is due to the extensive availability of OTC dermatological treatments on the market, the current high prevalence of skin diseases, and the presence of some of the leading market players in the region. Due to the high prevalence of dermatological illnesses, the growing elderly population, and the presence of some of the major players in the region, it is therefore anticipated that the North American region will hold a significant position in the market for dermatological OTC medications throughout the course of the study.

Dermatology OTC Medications Market: Key Players

Due to the presence of some major manufacturers, there is intense competition in the market for flexographic printing machines. The major players in the global Dermatology OTC medications market are; Abbvie Inc., Acella Pharmaceuticals, LLC, Allergan plc, Almirall S.A., Amgen, Astellas, Bausch Health Companies Inc., Bayer AG, Dr. Reddy's Laboratories, Galderma, GlaxoSmithKline plc., Johnson and Johnson Services, Inc., Le- Pharma A/S, Lumion Life, Perrig- Company plc, and Viatris Inc. amongst others.

Dermatology OTC Medications Market: Segmentation Outlook

Data for growth projections and estimates are included in this study for the Formulation segment{Solid Dosage Forms (Tablets, Capsules, Granules, Soaps); Liquid Dosage Forms (Syrups, Oils, Washes, Foams); Semi-solid Dosage Forms (Gels, Ointments, Creams, Shampoo)}; for the Route of Administration segment (Oral and Topical); for the Indication segment (Acne, Dermatitis, Dryness, Hyper-pigmentation, Psoriasis, and Skin Bleaching);  for the Age Group segment (Adult, Pediatrics, and Pregnant Women); for the Drug Type segment (Bacitracin, Benzyl benzoate, Betadine, Clotrimazole, Hydrocortisone, Ketoconazole, Neosporin, Polysporin, Terbinafine, and Others). The dermatology OTC medications market forecast period is 2022 to 2030.

 

Contact Us

Reports and Insights

Tel: +1-(718)-312-8686

For Sales Query[email protected]

For New Topics & Other Info: [email protected]

Websitehttps://reportsandinsights.com





This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK